1. Home
  2. MORN vs PCVX Comparison

MORN vs PCVX Comparison

Compare MORN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$176.97

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$59.63

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
PCVX
Founded
1984
2013
Country
United States
United States
Employees
N/A
507
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.4B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
MORN
PCVX
Price
$176.97
$59.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$256.50
$98.33
AVG Volume (30 Days)
433.4K
1.1M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.16%
N/A
EPS Growth
3.38
N/A
EPS
8.87
N/A
Revenue
$2,445,500,000.00
N/A
Revenue This Year
$9.02
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
$19.49
N/A
Revenue Growth
7.49
N/A
52 Week Low
$149.08
$28.09
52 Week High
$316.71
$65.00

Technical Indicators

Market Signals
Indicator
MORN
PCVX
Relative Strength Index (RSI) 52.33 59.41
Support Level $156.37 $42.30
Resistance Level $190.08 $65.00
Average True Range (ATR) 6.51 2.13
MACD 0.39 0.40
Stochastic Oscillator 65.05 91.30

Price Performance

Historical Comparison
MORN
PCVX

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: